According to the latest equity disclosure information from the Hong Kong Stock Exchange on June 21, Far East Grand Pharma (00512.HK) acquired 110,000 shares at an average price of HKD 4.78 per share from Executive Director and Chairman Tang Weikun on June 20, 2024, involving approximately HKD 525,800 in funds.
After the increase, Tang Weikun's latest shareholding is 681,000 shares.